Your browser doesn't support javascript.
loading
Neutron Radiation Therapy for Treatment of Refractory Merkel Cell Carcinoma.
Macomber, Meghan W; Tarabadkar, Erica S; Mayr, Nina A; Laramore, George E; Bhatia, Shailender; Tseng, Yolanda D; Liao, Jay; Arbuckle, Tom; Nghiem, Paul; Parvathaneni, Upendra.
Afiliação
  • Macomber MW; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Tarabadkar ES; Department of Medicine, Dermatology, University of Washington, Seattle, WA, USA.
  • Mayr NA; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Laramore GE; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Bhatia S; Department of Medicine, Medical Oncology Division, University of Washington, Seattle, WA, USA.
  • Tseng YD; Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Liao J; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Arbuckle T; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Nghiem P; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Parvathaneni U; Department of Medicine, Dermatology, University of Washington, Seattle, WA, USA.
Int J Part Ther ; 3(4): 485-491, 2017.
Article em En | MEDLINE | ID: mdl-31772998
ABSTRACT
We describe the first reported use of neutron radiation therapy for successful palliation of treatment refractory Merkel cell carcinoma. The patient was a 78-year-old man with Merkel cell carcinoma involving the scalp and bilateral cervical lymph nodes. The extensive coalescing scalp lesions were locally destructive, painful, and highly detrimental to his overall quality of life, and he had previously progressed through 3 courses of conventional x-ray-based radiation therapy and multiple immunotherapy regimens. We treated him with neutron radiation therapy, and he experienced a complete and durable local response with minimal toxicity. High linear energy transfer particle therapy approaches deserve consideration as a treatment option in cancers that are refractory to standard radiation therapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Part Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Part Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos